The development of innovative back braces has stagnated a bit. In part, this is because different patients have unique needs and there isn’t a comprehensive platform to test how new braces will help support different anatomies. Now, a team of engineers at Lancaster University in the U.K. has developed a torso simulator that can help researchers to design new back braces that are perfectly tuned to the needs of different people. The device mimics a male torso, including its mechanical...
When screening for cervical cancer, immunofluorescence staining is used to identify the presence of proteins that are biomarkers for the disease. It is a slow and meticulous process that requires lab technicians to prepare individual cells for analysis. Even then, since not all cells show the same disease characteristics, the rate of false negatives can be very high. Now, a new device developed by scientists at the University of Tokyo and Teikyo University School of Medicine in Japan...
A research team at a university hospital in Korea is drawing keen attention as it demonstrated excellent performance by reducing the amount of radiation exposure and procedure times using the EPI-Detection®, a digital medical pressure checker from Saeum Meditec, compared to traditional Loss of Resistance (LOR) technique. Epi-Detection® is expected to play a role in helping to secure procedures as the physician finds out that the needle for epidural infusion has safely reached the epidural...
Nuclear medicine relies on two imaging modalities to assess internal function and diagnose disease. Positron emission tomography (PET) typically uses fluorine-18, a radiotracer that releases positrons, and a special scanner to detect the resulting gamma rays. Single-photon emission computed tomography (SPECT) is similar, but usually depends on injecting the technetium-99m radioisotope and a gamma camera to detect where it goes in the body. Each modality has its benefits and drawbacks, and...
Cancer metastasis continues to pose difficulties for clinicians. Tumors shed cells which travel throughout the body and attach themselves at distant sites, causing new tumors to sprout. These so-called circulating tumor cells (CTCs) are extremely rare and difficult to pick out from whole blood, in part because they’re often a similar size to white blood cells. While researchers have built various devices that filter out CTCs from whole blood, they have all suffered from either poor performance, high...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου